Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome

Journal of Pediatric Oncology Nursing

Volumn 22, Issue 1, 2005, Pages 8-19

  Tate, Elizabeth D ^a,d   Allison, Tyler J ^b   Pranzatelli, Michael R ^a,b,c   Verhulst, Steven J ^d  

^a National Pediatric Myoclonus Center   (United States)

^b Department of Neurology ^*

^c Div of Child and Adol Neurology

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ataxia; Kinsbourne syndrome; Neuroblastoma; Paraneoplastic syndrome

Indexed keywords

CORTICOTROPIN; IMMUNOGLOBULIN; PREDNISONE;

ARTICLE; AUTOIMMUNE DISEASE; BEHAVIOR DISORDER; CANCER SURGERY; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ERROR; HEALTH SURVEY; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MUSCLE TONE; MYOCLONUS; NEUROBLASTOMA; NEUROLOGIC DISEASE; OPSOCLONUS; OPSOCLONUS MYOCLONUS SYNDROME; PRESCHOOL CHILD; QUESTIONNAIRE; SPEECH DISORDER;

ACCIDENTAL FALLS; ADRENOCORTICOTROPIC HORMONE; AGE OF ONSET; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC ERRORS; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; INFANT; MALE; MUSCLE HYPOTONIA; NEUROBLASTOMA; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; POPULATION SURVEILLANCE; PREDNISONE; PREVALENCE; QUESTIONNAIRES; RECURRENCE; REGISTRIES; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SPEECH DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 11844260145     PISSN: 10434542     EISSN: None     Source Type: Journal    
DOI: 10.1177/1043454204272560     Document Type: Article

References (36)

1. Boltshauser, E., Deonna, T., & Hirt, H. R. (1979). Myoclonic encephalopathy of infants or "dancing eyes syndrome." Helvetica Paediatrica Acta, 34, 119-133.
2. Connolly, A. M., Dodson, W. E., Prensky, A. L., & Rust, R. S. (1994). Course and outcome of acute cerebellar ataxia. Annals of Neurology, 35, 673-679.
3. Cooper, R., Khakoo, Y., Matthay, K. K., Lukens, J. N., Seeger, R. C., Stram, D. O., et al. (2001). Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Histopathologic features - a report from the Children's Cancer Group. Medical and Pediatric Oncology, 36, 623-629.
4. Cushing, H., & Wolbach, S. B. (1927). The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. American Journal of Pathology, 3, 203-205.
5. Edmondson, J. C., Nichter, C. A., Selman, J. E., & DeVivo, D. C. (1992). Use of intravenous gamma globulin therapy for postinfectious acute cerebellar ataxia/opsoclonus of childhood [abstract]. Annals of Neurology, 32, 440.
6. Estrin, W. J. (1977). The serological diagnosis of St. Louis encephalitis in a patient with the syndrome of opsoclonia, body tremulousness and benign encephalitis. Annals of Neurology, 1, 596-598.
7. Everson, T. C., & Cole, W. H. (1966). Spontaneous regression of neuroblastoma. In T. C. Everson & W. H. Cole (Eds.), Spontaneous regression of cancer (pp. 88-163). Philadelphia: W. B. Saunders.
8. Gennery, A. J., Cant, A., & Forsyth, R. J. (2001). Development of parainfectious opsoclonus in an infant by a non-humoral immune mechanism. Developmental Medicine and Child Neurology, 43, 213-216.
9. Haase, G. M., Perez, C., & Atkinson, J. B. (1999). Current aspects of biology, risk assessment, and treatment of neuroblastoma. Seminars in Surgical Oncology, 16, 91-104.
10. Hayward, K., Jeremy, R. J., Jenkins, S., Barkovich, A. J., Gultekin, S. H., Kramer, J., et al. (2001). Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: Relationship to MRI findings and anti-neuronal antibodies. Journal of Pediatrics, 139, 552-559.
11. Kinsbourne, M. (1962). Myoclonic encephalopathy of infants. Journal of Neurology, Neurosurgery, and Psychiatry, 25, 271-276.
12. Koh, P. S., Raffensperger, J. G., Berry, S., Larsen, M. B., Johnstone, H. S., Chou, P., et al. (1994). Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. Journal of Pediatrics, 125, 712-716.
13. Kuban, K. C., Ephros, M. A., Freeman, R. I., Laffell, L. B., & Bresnan, M. J. (1983). Syndrome of opsoclonus-myoclonus caused by coxsackie B3 infection. Annals of Neurology, 13, 69-71.
14. McMinn, P., Stratov, I., Nagarajan, L., & Davis, S. (2001). Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot and mouth disease in Western Australia. Clinical Infectious Diseases, 32, 236-242.
15. Mitchell, W. G., Davalos-Gonzalez, Y., Brumm, V. L., Aller, S. K., Burger, E., Turkel, S. B., et al. (2002). Opsoclonus-ataxia caused by childhood neuroblastoma: Developmental and neurologic sequelae. Pediatrics, 109, 86-98.
16. Mitchell, W. G., & Snodgrass, S. R. (1990). Opsoclonus-ataxia due to childhood neural crest tumors: A chronic neurologic syndrome. Journal of Child Neurology, 5, 153-158.
17. Nishihara, H., Toyoda, Y., Tanaka, Y., Ijira, R., Aida, N., Takeuchi, M., et al. (2000). Natural course of neuroblastoma detected by mass screening: A 5-year prospective study at a single institution. Journal of Clinical Oncology, 18, 3012-3017.
18. Papero, P. H., Pranzatelli, M. R., Margolis, L. J., Tate, E., Wilson, L. A., & Glass, P. (1995). Neurobehavioral and psychosocial functioning of children with opsoclonus-myoclonus syndrome. Developmental Medicine and Child Neurology, 37, 915-932.
19. Petruzzi, M. J., & deAlarcon, P. A. (1995). Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G. Journal of Pediatrics, 127, 328-329.
20. Pohl, K. R. E., Pritchard, J., & Wilson, J. (1996). Neurological sequelae of the dancing eye syndrome. European Journal of Pediatrics, 155, 237-244.
21. Posada, J. C., & Tardo, C. (1998). Neuroblastoma detected by somatostatin receptor scintigraphy in a case of opsoclonus-myoclonus-ataxia syndrome. Journal of Child Neurology, 13, 345-346.
22. Pranzatelli, M. R. (1992). The neurobiology of opsoclonus-myoclonus syndrome. Clinical Neuropharmacology, 15, 186-228.
23. Pranzatelli, M. R. (2004). Neuroblastoma masquerading as benign childhood ataxia: An unrecognized medical emergency. Journal of Emergency Medicine, 26, 242-243.
24. Pranzatelli, M. R., Huang, Y.-y., Tate, E., Goldstein, D. S., Holmes, C. S., Goldstein, E. M., et al. (1998). Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus. Movement Disorders, 13, 522-528.
25. Pranzatelli, M. R., Tate, E. D., Kinsbourne, M., Caviness, V. S., & Mishrah, B. (2002). Forty-one year follow-up of childhood-onset opsoclonus-myoclonus: Cerebellar atrophy, multiphasic relapses, response to IVIG. Movement Disorders, 17, 1387-1390.
26. Pranzatelli, M. R., Tate, E. D., Wheeler, A., Bass, N., Gold, A. P., Griebel, M. L., et al. (2002). Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia. Pediatric Neurology, 27, 384-387.
27. Pranzatelli, M. R., Travelstead, A. L., Tate, E. D., Allison, T. J., Moticka, E. J., Franz, D. N., et al. (2004). B-and T-cell markers in opsoclonus-myoclonus syndrome: Immunophenotyping of CSF lymphocytes. Neurology, 62, 1526-1532.
28. Rudnick, E., Khakoo, Y., Antunes, N., Seeger, R., Brodeur, G., Shimada, H., et al. (2001). Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and anti-neural antibodies - a Children's Cancer Group Study. Medical and Pediatric Oncology, 36, 612-622.
29. Russo, C., Cohn, S. L., Petruzzi, M. J., & deAlarcon, P. A. (1997). Long term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: A report from the Pediatric Oncology Group. Medical and Pediatric Oncology, 28, 284-288.
30. SAS Institute Inc. (2002). SAS/STAT user's guide, release 8.2 ed. Cary, NC: SAS Institute Inc.
31. Shapiro, B. (1995). Ten years of experience with MIBG applications and potential of new radiolabeled peptides: A personal overview and concluding remarks. Quarterly Journal of Nuclear Medicine, 39, 150-155.
32. Sheth, R. D., Horwitz, S. J., Aronoff, S., Gingold, M., & Bodensteiner, J. B. (1995). Opsoclonus myoclonus syndrome secondary to Epstein-Barr virus infection. Journal of Child Neurology, 10, 297-299.
33. Solomon, G. E., & Chutorian, A. M. (1968). Opsoclonus and occult neuroblastoma. New England Journal of Medicine, 279, 475-477.
34. Sugie, H., Sugie, Y., Akimoto, H., Endo, K., & Shirai, M. (1992). High-dose IV human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome. Acta Paediatrica, 18, 371-372.
35. Tabarki, B., Palmer, P., Lebon, P., & Sébire, G. (1998). Spontaneous recovery of opsoclonus-myoclonus syndrome caused by enterovirus infection. Journal of Neurology, Neurosurgery, and Psychiatry, 64, 406-422.
36. Talon, P., & Stoll, C. (1985). Opso-myoclonus syndrome of infancy: New observations - Review of the literature (110 cases). Pédià trie, 40, 441-449.